Cargando…
Axitinib targets cardiac fibrosis in pressure overload-induced heart failure through VEGFA-KDR pathway
BACKGROUND: There are no specific clinical medications that target cardiac fibrosis in heart failure (HF). Recent studies have shown that tyrosine kinase inhibitors (TKIs) may benefit fibrosis in various organs. However, there is limited research on their application in cardiac fibrosis. Axitinib, a...
Autores principales: | Jiao, Tiantian, Wang, Yuanqi, Lin, Xueqi, Song, Wei, Wang, Liang, Rahman, Tapu Md Sakibur, Xu, Linghao, Nie, Lindong, Zhang, Qi, Li, Jiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667428/ https://www.ncbi.nlm.nih.gov/pubmed/38020087 http://dx.doi.org/10.3389/fmed.2023.1256156 |
Ejemplares similares
-
The Prognostic Significance of Combining VEGFA, FLT1 and KDR mRNA Expressions in Brain Tumors
por: Zhang, Shu-Dong, et al.
Publicado: (2015) -
The significance of combining VEGFA, FLT1, and KDR expressions in colon cancer patient prognosis and predicting response to bevacizumab
por: Zhang, Shu-Dong, et al.
Publicado: (2015) -
Molecular Mechanism of HSF1-Upregulated ALDH2 by PKC in Ameliorating Pressure Overload-Induced Heart Failure in Mice
por: Ji, Endong, et al.
Publicado: (2020) -
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017) -
Morphological and Functional Characteristics of Animal Models of Myocardial Fibrosis Induced by Pressure Overload
por: Ding, Yuejia, et al.
Publicado: (2020)